Quick Answer
Regenerative Medical Technology Group Inc. reported Operating Income Loss of $81.2 thousand for the year ending 2024.
- Regenerative Medical Technology Group Inc. showed an increase of +111.4% in Operating Income Loss from 2023 to 2024.
- This data is from Regenerative Medical Technology Group Inc.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
- XBRL data for this metric is available from 2023 to 2024 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2024: $81.2 thousand | Fiscal year 2023: -$715.2 thousand.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: